Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
BMC Cancer|April 1, 2021
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapyShanshan Chen, Yiqun Han, Quchang Ouyang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
A prospective phase II trial of hypofractionated stereotactic radiotherapy (FSRT) for patients with 1-10 brain metastases from breast cancerJin Meng, Li Zhang, Jingyao Chen, et al.
Radiation Oncology (London, England)|July 1, 2023
Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesionsWei Shi, Yang Li, Hua Sun, et al.
Breast Cancer Research : BCR|April 13, 2017
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1Masakazu Toi, Zhimin Shao, Sara Hurvitz, et al.
Scientific Reports|January 31, 2025
Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trialXiaomeng Zhang, Xiaofang Wang, Zhuohua Xu, et al.
Oncogene|March 26, 2021
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancerXiaoshuang Wang, Mei Feng, Tengfei Xiao, et al.
BMC Cancer|January 9, 2024
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trialLi Zhang, Xin Mei, Zhigang Hu, et al.
The Oncologist|April 26, 2020
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 HospitalsBenlong Yang, Guosheng Ren, Erwei Song, et al.
JAMA Oncology|August 26, 2021
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical TrialYing Fan, Tao Sun, Zhimin Shao, et al.
BMC Cancer|September 13, 2024
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancerQingyuan Zhang, Zhonghua Wang, Wei Yao, et al.
Pageof 21